跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Apixero 5 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Apixero 5
Approved
STANDARD
Apixero 5
Hetero Labs Limited (Unit V)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cb185dcc69ed760f
Company
Hetero Labs Limited (Unit V)
Type
Standard
Approval Details
Approval Id
cb185dcc69ed760f
Drug Approval Philippines Name
Apixero 5
Product Name
Apixero 5
Registration Number
DRP-16283
Brand Name
Apixero 5
Generic Name
Apixaban
Dosage Form
Film Coated Tablet
Dosage Strength
5 mg
Manufacturer
Hetero Labs Limited (Unit V)
Importer
Camber Pharmaceuticals Inc.
Distributor
Camber Pharmaceuticals Inc.
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Distributor Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
27 January 2025
Expiry Date
27 January 2030
Pharmacologic Category
Direct Factor Xa inhibitor
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cb185dcc69ed760f
Type
Standard
Back to Philippines FDA Approvals